SUTRO BIOPHARMA, INC. (STRO) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$102.5M

Net Income/Loss (FY2025)

-$191.1M

Total Assets (FY2025)

$173.8M

Total Equity (FY2025)

-$132.5M

Cash Flows from Operating Activities (FY2025)

-$177.2M

Source: SUTRO BIOPHARMA, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.